Ian Henderson, Hopewell US
Ian Henderson, Hopewell, NJ US
Patent application number | Description | Published |
---|---|---|
20080249100 | PTERIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS - The present invention discloses pteridinone derivatives for use as inhibitors of stearoyl-CoA desaturase having the structure of Formula I: | 10-09-2008 |
20080312215 | Substituted [1,4]-diazepanes as CXCR3 antagonists and their use in the treatment of inflammatory disorders - CXCR3 inhibitors of formula | 12-18-2008 |
20090005568 | Substituted 2-aminothiazoles for treating neurodegenerative diseases - The invention relates to substituted 2-aminothiazole derivatives useful in treating disorders that are mediated by A | 01-01-2009 |
20090023723 | Purinone derivatives for treating neurodegenerative diseases - The invention relates to purinone derivatives useful in treating disorders that are mediated by adenosine receptor function, including neurodegenerative diseases and inflammation. The compounds are of the general formula: | 01-22-2009 |
20090312320 | METHODS OF TREATMENT COMPRISING THE ADMINISTRATION OF HALOARYL SUBSTITUTED AMINOPURINES OR COMPOSITIONS THEREOF - Provided herein are Aminopurine Compounds having the following structure: | 12-17-2009 |
20100113463 | PTERIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS - The present invention discloses pteridinone derivatives for use as inhibitors of stearoyl-CoA desaturase having the structure of Formula I: | 05-06-2010 |
20110071130 | 2-AMINOBENZIMIDAZOLES FOR TREATING NEURODEGENERATIVE DISEASES - The invention relates to 2-aminobenzimidazoles useful in treating disorders that are mediated by A | 03-24-2011 |
20110230480 | 8-HETEROARYLPURINE MNK2 INHIBITORS FOR TREATING METABOLIC DISORDERS - Compounds of the formula | 09-22-2011 |